Bio Essence Corp
BIOE· OTC
BIOEBio Essence Corp
Filed Nov 12, 2021 · 10-Q · 43 days after period end · 0001213900-21-058632
| Metric | Q3 2021 | Q3 2020 |
|---|---|---|
| Revenue | $226.99K | $228.33K |
| Net Income | -$183.04K | -$204.71K |
| EPS Diluted | -$0.01 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Essence Corp · CIK 1723059 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 12, 2021 · 43 d after period end
